Document Detail


The effects of long-term GH and IGF-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
MedLine Citation:
PMID:  21521288     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background:  Acromegaly is characterised by the hyper-secretion of GH and IGF-1. This leads to an increased cardiovascular, cerebrovascular and metabolic morbidity resulting in excess mortality. There is controversy over which biomarker, GH or IGF-1, better predicts this increased morbidity and mortality. The relationship between the cumulative exposure to GH and IGF-1 with co-morbidities in acromegaly has not previously been reported. Objective:  To investigate the relationship between the cumulative exposure to GH and IGF-1 with cardiovascular, cerebrovascular and metabolic co-morbidities. Methods:  Records of 116 acromegalic patients were retrospectively examined. Cardiovascular and cerebrovascular histories, serum GH and IGF-1, fasting glucose and oral glucose tolerance (OGTT) results, were reviewed for the duration of follow-up. IGF-1 index was calculated by dividing each serum IGF-1 value by the upper limit of reference range for IGF-1. GH and IGF-1 burdens were calculated for each patient by multiplying known disease duration (in years) by mean level of basal GH or IGF-1 index recorded during the patients' entire follow-up. Results:  Patients with abnormal glucose tolerance had a significantly higher mean GH burden compared with euglycaemic patients (P = 0.005). Ischaemic heart disease (IHD) was also associated with a higher GH burden (P = 0.009) whereas cerebrovascular disease and cardiomyopathy were associated with a significantly higher mean IGF-1 burden (P = 0.018, P = 0.011 respectively). Conclusion:  This study identifies associations of raised GH and IGF-1 burden with cardiovascular, cerebrovascular and metabolic complications of acromegaly. Results from this study therefore suggest that consideration of the overall level of GH and IGF-1 exposure may provide important information for the management and surveillance of patients with treated acromegaly.
Authors:
Cn Jayasena; An Comninos; H Clarke; M Donaldson; K Meeran; Ws Dhillo
Related Documents :
7953058 - Neuropathological correlates of psychotic phenomena in confirmed alzheimer's disease.
1448238 - Patterns of regional cerebral blood flow in alzheimer's disease.
10923058 - Cognitive decline in patients with familial alzheimer's disease associated with e280a p...
12675388 - Neuropsychological screening for cognitive impairment using computer-assisted tasks.
12043778 - The contour of the femoral head-neck junction as a predictor for the risk of anterior i...
20942938 - Parasites in mexican patients with irritable bowel syndrome: a case-control study.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-23
Journal Detail:
Title:  Clinical endocrinology     Volume:  -     ISSN:  1365-2265     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-4-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0346653     Medline TA:  Clin Endocrinol (Oxf)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Blackwell Publishing Ltd.
Affiliation:
Department of Endocrinology, Imperial College London Faculty of Medicine, Hammersmith Hospital, Du Cane Road, London W12 OHS.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Endogenous Oestradiol but Not Testosterone Is Related to Coronary Artery Disease in Men Sex hormones...
Next Document:  Early Diagnosis of Acromegaly: Computers Versus Clinicians.